These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33072167)

  • 1. Changes in alanine aminotransferase in adults with severe and complicated obesity during a milk-based meal replacement programme.
    Abdalgwad R; Rafey MF; Murphy C; Ioana I; O'Shea PM; Slattery E; Davenport C; O'Keeffe DT; Finucane FM
    Nutr Metab (Lond); 2020; 17():87. PubMed ID: 33072167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Changes in Weight in Patients With Severe and Complicated Obesity After Completion of a Milk-Based Meal Replacement Programme.
    Abdalgwad R; Rafey MF; Foy S; Newell M; Davenport C; O'Keeffe DT; Finucane FM
    Front Nutr; 2020; 7():551068. PubMed ID: 33117840
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of a Milk-Based Meal Replacement Program on Weight and Metabolic Characteristics in Adults with Severe Obesity.
    Rafey MF; Murphy CF; Abdalgwad R; Kilkelly K; Griffin H; Beatty N; O'Shea PM; Collins C; McGrath R; Hynes M; Davenport C; O'Donnell M; Finucane FM
    Diabetes Metab Syndr Obes; 2020; 13():197-205. PubMed ID: 32158243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive lifestyle intervention
    Deibert P; Lazaro A; Schaffner D; Berg A; Koenig D; Kreisel W; Baumstark MW; Steinmann D; Buechert M; Lange T
    World J Gastroenterol; 2019 Mar; 25(9):1116-1131. PubMed ID: 30862999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
    Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
    Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher Waist Hip Ratio Genetic Risk Score Is Associated with Reduced Weight Loss in Patients with Severe Obesity Completing a Meal Replacement Programme.
    Handley D; Rafey MF; Almansoori S; Brazil JF; McCarthy A; Amin HA; O'Donnell M; Blakemore AI; Finucane FM
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579607
    [No Abstract]   [Full Text] [Related]  

  • 8. Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease.
    de Jonge C; Rensen SS; Koek GH; Joosten MF; Buurman WA; Bouvy ND; Greve JW
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1517-20. PubMed ID: 23920034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilising a milk-based meal replacement programme in a bariatric patient with poorly controlled type 2 diabetes mellitus.
    Maher M; Rafey MF; Griffin H; Cunningham K; Finucane FM
    Endocrinol Diabetes Metab Case Rep; 2019 Apr; 2019():. PubMed ID: 30959473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the longitudinal assessment of bariatric surgery (LABS) study.
    Kleiner DE; Berk PD; Hsu JY; Courcoulas AP; Flum D; Khandelwal S; Pender J; Pomp A; Roerig J; Machado LL; Wolfe BM; Belle SH;
    Semin Liver Dis; 2014 Feb; 34(1):98-107. PubMed ID: 24782263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
    Sorbi D; Boynton J; Lindor KD
    Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
    Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivation and validation of a scoring system for predicting nonalcoholic steatohepatitis in Taiwanese patients with severe obesity.
    Tai CM; Yu ML; Tu HP; Huang CK; Hwang JC; Chuang WL
    Surg Obes Relat Dis; 2017 Apr; 13(4):686-692. PubMed ID: 28089433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease.
    Ooi GJ; Burton PR; Doyle L; Wentworth JM; Bhathal PS; Sikaris K; Cowley MA; Roberts SK; Kemp W; Earnest A; O'Brien PE; Brown WA
    Obes Surg; 2017 Jun; 27(6):1533-1542. PubMed ID: 27966066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of MK615 for the treatment of patients with liver disorders.
    Hokari A; Ishikawa T; Tajiri H; Matsuda T; Ishii O; Matsumoto N; Okuse C; Takahashi H; Kurihara T; Kawahara K; Maruyama I; Zeniya M
    World J Gastroenterol; 2012 Aug; 18(31):4118-26. PubMed ID: 22919243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.
    Shidfar F; Bahrololumi SS; Doaei S; Mohammadzadeh A; Gholamalizadeh M; Mohammadimanesh A
    Can J Gastroenterol Hepatol; 2018; 2018():1053710. PubMed ID: 29850450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe nonalcoholic steatohepatitis and type 2 diabetes: liver histology after weight loss therapy in a randomized clinical trial.
    Oshakbayev K; Bimbetov B; Manekenova K; Bedelbayeva G; Mustafin K; Dukenbayeva B
    Curr Med Res Opin; 2019 Jan; 35(1):157-165. PubMed ID: 30431378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers.
    Chan WK; Sthaneshwar P; Nik Mustapha NR; Mahadeva S
    PLoS One; 2014; 9(9):e105903. PubMed ID: 25184298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis.
    Hoofnagle JH; Van Natta ML; Kleiner DE; Clark JM; Kowdley KV; Loomba R; Neuschwander-Tetri BA; Sanyal AJ; Tonascia J;
    Aliment Pharmacol Ther; 2013 Jul; 38(2):134-43. PubMed ID: 23718573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
    Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.